SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Arvind Remedies establishes Rs 250-crore manufacturing facility near Chennai

26 Jun 2013 Evaluate

Arvind Remedies has established an Rs 250-crore manufacturing facility at Irungattukottai, near Chennai, in order to tap the US market. It has begun with testing and development of analgesic and cardiac generic drugs (tablets) at the plant, which will seek USFDA approval in next six months.

The company has also established a subsidiary in New Jersey to take care of its US strategy. It is likely to distribute its drugs in the US and also get into contract manufacturing for other American pharma companies.

 

Peers
Company Name CMP
Sun Pharma Inds. 1669.50
Dr. Reddys Lab 1216.60
Cipla 1239.65
Zydus Lifesciences 928.00
Lupin 2300.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×